Teva Pharmaceutical Industries Ltd. - Financials - Debt Securities

Teva's senior notes and debentures and convertible debentures are issued by various special-purpose finance subsidiaries. All such debt is guaranteed by Teva Pharmaceutical Industries Ltd.

Quarterly Debt Factsheet

Senior Notes and Sustainability-Linked Senior Notes

Issued	Currency	Annual Interest (%)	Principal Amount Issued (issuance currency, in millions)	Outstanding Principal Amount (issuance currency, in millions)	Outstanding Principal Amount (U.S. $, in millions)	Due	Prospectuses
July 2016	USD	3.150	3,500	1,798	1,798	October 2026
March 2015	Euro	1.875	700	700	800	March 2027
November 2021	Euro	3.750	1,100	1,100	1,256	May 2027
November 2021	USD	4.750	1,000	649	649	May 2027
March 2018	USD	6.750	1,250	1,250	1,250	March 2028
July 2016	Euro	1.625	750	750	857	October 2028
November 2021	USD	5.125	1,000	1,000	1,000	May 2029
March 2023	Euro	7.375	800	663	757	September 2029
March 2023	USD	7.875	600	398	398	September 2029
November 2021	Euro	4.375	1,500	1,500	1,713	May 2030
May 2025	USD	5.750	700	700	700	December 2030
May 2025	Euro	4.125	1,000	1,000	1,142	June 2031
March 2023	Euro	7.875	500	500	571	September 2031
March 2023	USD	8.125	500	500	500	September 2031
May 2025	USD	6.000	500	500	500	December 2032
February 2006	USD	6.150	1,000	789	789	February 2036
July 2016	USD	4.100	2,000	2,000	2,000	October 2046